AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

AZATHIOPRINE (Oral route, Intravenous route) - ay-za-THYE-oh-preen.(Drug overview)

USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language

| May 01, 2007 | COPYRIGHT 1996 USP DIĀ® and Advice for the PatientĀ® are registered trademarks of USP used under license to Micromedex, Inc. (Hide copyright information)Copyright

Warning --

Chronic immunosuppression with this purine antimetabolite increases risk of neoplasia in humans. Physicians using this drug should be very familiar with this risk as well as with the mutagenic potential to both men and women and with possible hematologic toxicities .

Brand names in the United States --

* Azasan

* Imuran

Dosage forms --

* Tablet

* Powder for Solution

Therapeutic classification: Antirheumatic, Cytotoxic

Pharmacologic classification: Antimetabolite

DESCRIPTION OF USE

Azathioprine belongs to the group of medicines known as immunosuppressive agents. It is used to reduce the body's natural immunity in patients who receive organ transplants. It is also used to treat rheumatoid arthritis. Azathioprine may also be used for other conditions as determined by your doctor.

Azathioprine is a very strong medicine. You and your doctor should talk about the need for this medicine and its risks. Even though azathioprine may cause side effects that could be very serious, remember that it may be required to treat your medical problem.

Azathioprine is available only with your doctor's prescription.

Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, azathioprine is used in certain patients with the following medical conditions:

* Bowel disease, inflammatory

* Cirrhosis, biliary

* Dermatomyositis, systemic

* Glomerulonephritis

* Hepatitis, chronic active

* Lupus erythematosus, systemic

* Myasthenia gravis

* Myopathy, inflammatory

* Nephrotic syndrome

* Pemphigoid

* Pemphigus

BEFORE USING THIS MEDICINE

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies --

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care …

Related articles from newspapers, magazines, journals, and more
Genelabs announces publication in New England Journal of Medicine of clinical...
News wire article from: Chemical Business Newsbase March 1, 2007 700+ words
Varicella Virus Vaccine Live (Systemic).
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language October 27, 2005 700+ words
Varicella Virus Vaccine Live (Systemic).(Drug overview)
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language May 1, 2006 700+ words
Rubella and Mumps Virus Vaccine Live (Systemic).
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language July 28, 2005 700+ words
Rubella and Mumps Virus Vaccine Live (Systemic).(Drug overview)
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language May 1, 2006 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily